Aequus Pharmaceuticals Inc (AQS : TSX-V)
Common Stock
Follow AQS
AQS
Aequus Pharmaceuticals Inc
WealthAwesomePerformance
1 Day
+0.00%
1 Week
+0.00%
1 Month
+0.00%
YTD
+0.00%
The Saturday TSX Wrap · free, every saturday morning. The week on the TSX, in five minutes.
Key Statistics
Market Cap
$663,172
52W High
$0.01
52W Low
$0.01
P/E Ratio
-
50 Day MA
$0.01
200 Day MA
$0.01
Beta
-0.29
Dividend Yield
-
Performance history
AQS returns since 2023
Aequus Pharmaceuticals Inc has traded since Nov 2023 in our data, with 0 up years out of 2 full calendar years. Its deepest fall was −88.9% (Nov 2023 to Nov 2024).
1 year / yr
0.0%
3 years / yr
—
5 years / yr
—
10 years / yr
—
Calendar-year returns
- 2023*−44.4%
- 2024−60.0%
- 2025−50.0%
- 2026*0.0%
* Partial year (first year of data, or year to date).
$10,000 invested in AQS
- 1 year ago$10,000
- 2023 (start of our data)$1,111
- Best year
- 2025: −50.0%
- Worst year
- 2024: −60.0%
- All-time high in our data
- $0 on Nov 9, 2023 · now −88.9%
Total-return basis using adjusted daily closes from the Toronto Stock Exchange and TSX Venture (dividends and splits folded in), Nov 2023 to Apr 2026. Past returns do not predict future ones.
Awesome Portfolio™
Looking past AQS? Our 10 best Canadian stocks, in one list.
14.8% a year since 2017 against 9.7% for the S&P/TSX Composite (+5.0 points a year). Reviewed every month.
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 4/10/2026 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 0 |
| 4/9/2026 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 0 |
| 4/8/2026 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 0 |
| 4/7/2026 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 0 |
| 4/6/2026 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 0 |
| 4/2/2026 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 0 |
| 4/1/2026 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 0 |
| 3/31/2026 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 0 |
| 3/30/2026 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 0 |
| 3/27/2026 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 0 |
Analyst Price Targets
Based on analyst covering AQS · as of Sep 17, 2026
Wall Street analysts forecast AQS stock price to rise 50300.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$2.52
+50300.0% Upside
Current Price
C$0.01
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on AQS's historical volatility
30-Day Vol
0.0%
Annualized
90-Day Vol
0.0%
Annualized
Trend (90d)
+0.0%
Annualized drift
90d Mean
C$0.01
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.01 | C$0.01 – C$0.01 |
| 60 trading days | C$0.01 | C$0.01 – C$0.01 |
| 90 trading days | C$0.01 | C$0.01 – C$0.01 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Aequus Pharmaceuticals Inc
Aequus Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. The company offers ZIMED PF, a preservative-free bimatoprost prescription drug for the for the reduction of elevated interocular pressure in patients with open angle glaucoma or ocular hypertension. It also develops REV-0100, which is in pre-clinical trial for the treatment of stargardt disease. Aequus Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in Vancouver, Canada.
Financials
- Revenue (TTM)
- $918,468
- EBITDA
- $-2.37M
- Profit Margin
- -71.46%
- ROE (TTM)
- -1569.60%
- EPS (Diluted)
- -0.02
- Book Value
- -0.05
Classification
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
Free newsletter
The Saturday TSX Wrap
The week on the TSX, in five minutes
- The biggest gainers and losers, and why they moved
- Sector and momentum moves at a glance
- The Canadian market stories you missed
Explore More
Common Questions About AQS
Market movers
Recent TSX-V movers
Top 1-day gainers — updated from our Canadian movers feed.